STOCK TITAN

[Form 4] Stryker Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

On 4 Aug 2025, La Rosa Holdings Corp. ("LRHC") filed an 8-K announcing it has entered into an Equity Purchase Facility Agreement (EPFA) with an institutional investor.

The facility gives LRHC the right—but not the obligation—to sell up to US$150 million of newly issued common shares over a period ending the earlier of (i) 36 months after the first trading day post-signing or (ii) when the commitment is fully drawn. Pricing will be based on the prevailing Market Price. The Company may cancel the EPFA with five trading days’ notice, provided no advance notices are outstanding.

To access the full commitment, LRHC must obtain stockholder approval (via meeting or written consent) within 60 days of the Agreement Date and file a Schedule 14C if approval is secured by consent. A companion Registration Rights Agreement obliges LRHC to file a resale registration statement within 60 days and have it declared effective within 90 days (or five business days after SEC clearance). Shares will be issued under the Section 4(a)(2) exemption.

The filing lists the EPFA and Registration Rights Agreement as Exhibits 10.1 and 10.2. No financial performance metrics were disclosed.

Il 4 agosto 2025, La Rosa Holdings Corp. («LRHC») ha depositato un 8-K annunciando la stipula di un Accordo di Facilità di Acquisto di Azioni (EPFA) con un investitore istituzionale.

La facilità concede a LRHC il diritto—ma non l'obbligo—di vendere fino a 150 milioni di dollari USA di azioni ordinarie di nuova emissione entro il termine che sarà il primo tra (i) 36 mesi dal primo giorno di negoziazione successivo alla firma, o (ii) il completo utilizzo dell'impegno. Il prezzo sarà basato sul Prezzo di Mercato prevalente. La Società può annullare l’EPFA con un preavviso di cinque giorni di negoziazione, a condizione che non vi siano notifiche anticipate in sospeso.

Per accedere all'intero impegno, LRHC deve ottenere l’approvazione degli azionisti (tramite assemblea o consenso scritto) entro 60 giorni dalla data dell’Accordo e depositare un Schedule 14C se l’approvazione è ottenuta tramite consenso scritto. Un Accordo sui Diritti di Registrazione correlato obbliga LRHC a presentare una dichiarazione di registrazione per la rivendita entro 60 giorni e a farla dichiarare efficace entro 90 giorni (o cinque giorni lavorativi dopo l’approvazione della SEC). Le azioni saranno emesse in base all’esenzione prevista dalla Sezione 4(a)(2).

Il deposito elenca l’EPFA e l’Accordo sui Diritti di Registrazione come Allegati 10.1 e 10.2. Non sono stati divulgati indicatori di performance finanziaria.

El 4 de agosto de 2025, La Rosa Holdings Corp. («LRHC») presentó un 8-K anunciando que ha firmado un Acuerdo de Facilidad de Compra de Acciones (EPFA) con un inversor institucional.

La facilidad otorga a LRHC el derecho—pero no la obligación—de vender hasta 150 millones de dólares estadounidenses en acciones ordinarias recién emitidas durante un periodo que termina al primero de (i) 36 meses después del primer día de negociación tras la firma, o (ii) cuando se haya utilizado el compromiso en su totalidad. El precio se basará en el Precio de Mercado vigente. La Compañía puede cancelar el EPFA con un aviso de cinco días hábiles, siempre que no haya avisos anticipados pendientes.

Para acceder al compromiso completo, LRHC debe obtener la aprobación de los accionistas (mediante reunión o consentimiento por escrito) dentro de 60 días desde la fecha del Acuerdo y presentar un Schedule 14C si la aprobación se obtiene por consentimiento. Un Acuerdo de Derechos de Registro asociado obliga a LRHC a presentar una declaración de registro para reventa dentro de 60 días y a que sea declarada efectiva dentro de 90 días (o cinco días hábiles tras la aprobación de la SEC). Las acciones se emitirán bajo la exención de la Sección 4(a)(2).

La presentación lista el EPFA y el Acuerdo de Derechos de Registro como Anexos 10.1 y 10.2. No se divulgaron métricas de desempeño financiero.

2025년 8월 4일, La Rosa Holdings Corp.("LRHC")는 기관 투자자와 주식 매입 시설 계약(EPFA)을 체결했다고 8-K 보고서를 통해 발표했습니다.

이 시설은 LRHC에 최대 1억 5천만 달러 상당의 신주 보통주를 판매할 권리(의무는 아님)를 부여하며, 계약 체결 후 첫 거래일 기준으로 (i) 36개월이 경과하거나 (ii) 약정금액이 전부 소진되는 시점 중 빠른 시점까지 유효합니다. 가격은 현재 시장 가격을 기준으로 결정됩니다. 회사는 미리 통지된 사항이 없으면 5거래일 전에 통지하여 EPFA를 취소할 수 있습니다.

전체 약정을 이용하려면 LRHC는 계약일로부터 60일 이내에 주주 승인(회의 또는 서면 동의)을 받아야 하며, 서면 동의로 승인을 받은 경우 Schedule 14C를 제출해야 합니다. 함께 체결된 등록 권리 계약은 LRHC가 60일 이내에 재판매 등록 서류를 제출하고 90일 이내(또는 SEC 승인 후 5영업일 이내)에 효력을 발생시키도록 의무화합니다. 주식은 섹션 4(a)(2) 면제를 통해 발행됩니다.

보고서에는 EPFA와 등록 권리 계약이 각각 부속서 10.1과 10.2로 기재되어 있습니다. 재무 성과 지표는 공개되지 않았습니다.

Le 4 août 2025, La Rosa Holdings Corp. (« LRHC ») a déposé un 8-K annonçant la conclusion d’un Contrat de Facilité d’Achat d’Actions (EPFA) avec un investisseur institutionnel.

Cette facilité donne à LRHC le droit—mais pas l’obligation—de vendre jusqu’à 150 millions de dollars US d’actions ordinaires nouvellement émises sur une période se terminant à la première échéance entre (i) 36 mois après le premier jour de négociation suivant la signature, ou (ii) lorsque l’engagement est entièrement utilisé. Le prix sera basé sur le prix du marché en vigueur. La société peut annuler l’EPFA avec un préavis de cinq jours de bourse, à condition qu’aucun avis préalable ne soit en attente.

Pour accéder à l’intégralité de l’engagement, LRHC doit obtenir l’approbation des actionnaires (par assemblée ou consentement écrit) dans les 60 jours suivant la date de l’accord et déposer un Schedule 14C si l’approbation est obtenue par consentement écrit. Un Accord sur les Droits d’Enregistrement associé oblige LRHC à déposer une déclaration d’enregistrement de revente dans les 60 jours et à la faire rendre effective dans les 90 jours (ou cinq jours ouvrables après l’approbation de la SEC). Les actions seront émises sous l’exemption de la Section 4(a)(2).

Le dépôt liste l’EPFA et l’Accord sur les Droits d’Enregistrement comme Annexes 10.1 et 10.2. Aucune donnée financière n’a été divulguée.

Am 4. August 2025 hat La Rosa Holdings Corp. („LRHC“) ein 8-K eingereicht, in dem bekanntgegeben wurde, dass eine Aktienkauf-Fazilitätsvereinbarung (EPFA) mit einem institutionellen Investor abgeschlossen wurde.

Die Fazilität gibt LRHC das Recht—aber nicht die Verpflichtung—bis zu 150 Millionen US-Dollar an neu ausgegebenen Stammaktien über einen Zeitraum zu verkaufen, der endet, je nachdem, was früher eintritt: (i) 36 Monate nach dem ersten Handelstag nach der Unterzeichnung oder (ii) wenn die Verpflichtung vollständig ausgeschöpft ist. Die Preisgestaltung erfolgt basierend auf dem aktuellen Marktpreis. Das Unternehmen kann die EPFA mit einer Frist von fünf Handelstagen kündigen, sofern keine Vorausbenachrichtigungen ausstehen.

Um die volle Verpflichtung in Anspruch zu nehmen, muss LRHC innerhalb von 60 Tagen nach dem Vertragsdatum die Aktionärszustimmung (durch Versammlung oder schriftliche Zustimmung) einholen und ein Schedule 14C einreichen, falls die Zustimmung schriftlich erfolgt. Eine begleitende Registrierungsrechtsvereinbarung verpflichtet LRHC, innerhalb von 60 Tagen eine Wiederverkaufsregistrierung einzureichen und diese innerhalb von 90 Tagen (oder fünf Werktagen nach SEC-Freigabe) wirksam werden zu lassen. Die Aktien werden gemäß der Section 4(a)(2)-Ausnahme ausgegeben.

Die Einreichung listet die EPFA und die Registrierungsrechtsvereinbarung als Anlagen 10.1 und 10.2 auf. Es wurden keine finanziellen Leistungskennzahlen offengelegt.

Positive
  • Access to up to $150 million in equity capital over 36 months enhances liquidity without incurring debt.
  • Company retains optional draw control and early termination rights, allowing strategic timing of share sales.
  • Execution risk mitigated by registration rights that mandate an effective resale shelf within 90 days.
Negative
  • Dilution risk to existing shareholders if a large portion of the facility is utilized at market prices.
  • Facility effectiveness is contingent on obtaining stockholder approval within 60 days, introducing timing risk.
  • Reliance on a single institutional investor could create market overhang and pricing pressure.

Insights

TL;DR: $150 m equity line bolsters liquidity, but dilution hinges on usage and pricing.

The EPFA provides LRHC with flexible, on-demand access to up to $150 m, materially expanding financing capacity without immediate debt. Such facilities often lower cost of capital versus traditional offerings and can be tapped opportunistically. However, investor purchase prices track market levels, so heavy utilization during price weakness could create substantial dilution and pressure the share price. Mandatory stockholder approval within 60 days and registration undertakings introduce execution risk but are standard for Nasdaq-listed issuers. Overall impact is modestly positive, enhancing liquidity while leaving dilution timing under management control.

TL;DR: Shareholder vote and disclosure obligations are typical, but concentration with one investor raises governance watch-points.

The requirement to secure majority approval or written consent aligns with Nasdaq rules for significant share issuance. Filing of a Schedule 14C and resale registration statement promotes transparency. Yet, committing to a single institutional counter-party may concentrate bargaining power and expose minority holders to market overhang if advances are frequent. Termination flexibility provides some protection. Governance impact is neutral to slightly positive, contingent on clear communication during proxy solicitation.

Il 4 agosto 2025, La Rosa Holdings Corp. («LRHC») ha depositato un 8-K annunciando la stipula di un Accordo di Facilità di Acquisto di Azioni (EPFA) con un investitore istituzionale.

La facilità concede a LRHC il diritto—ma non l'obbligo—di vendere fino a 150 milioni di dollari USA di azioni ordinarie di nuova emissione entro il termine che sarà il primo tra (i) 36 mesi dal primo giorno di negoziazione successivo alla firma, o (ii) il completo utilizzo dell'impegno. Il prezzo sarà basato sul Prezzo di Mercato prevalente. La Società può annullare l’EPFA con un preavviso di cinque giorni di negoziazione, a condizione che non vi siano notifiche anticipate in sospeso.

Per accedere all'intero impegno, LRHC deve ottenere l’approvazione degli azionisti (tramite assemblea o consenso scritto) entro 60 giorni dalla data dell’Accordo e depositare un Schedule 14C se l’approvazione è ottenuta tramite consenso scritto. Un Accordo sui Diritti di Registrazione correlato obbliga LRHC a presentare una dichiarazione di registrazione per la rivendita entro 60 giorni e a farla dichiarare efficace entro 90 giorni (o cinque giorni lavorativi dopo l’approvazione della SEC). Le azioni saranno emesse in base all’esenzione prevista dalla Sezione 4(a)(2).

Il deposito elenca l’EPFA e l’Accordo sui Diritti di Registrazione come Allegati 10.1 e 10.2. Non sono stati divulgati indicatori di performance finanziaria.

El 4 de agosto de 2025, La Rosa Holdings Corp. («LRHC») presentó un 8-K anunciando que ha firmado un Acuerdo de Facilidad de Compra de Acciones (EPFA) con un inversor institucional.

La facilidad otorga a LRHC el derecho—pero no la obligación—de vender hasta 150 millones de dólares estadounidenses en acciones ordinarias recién emitidas durante un periodo que termina al primero de (i) 36 meses después del primer día de negociación tras la firma, o (ii) cuando se haya utilizado el compromiso en su totalidad. El precio se basará en el Precio de Mercado vigente. La Compañía puede cancelar el EPFA con un aviso de cinco días hábiles, siempre que no haya avisos anticipados pendientes.

Para acceder al compromiso completo, LRHC debe obtener la aprobación de los accionistas (mediante reunión o consentimiento por escrito) dentro de 60 días desde la fecha del Acuerdo y presentar un Schedule 14C si la aprobación se obtiene por consentimiento. Un Acuerdo de Derechos de Registro asociado obliga a LRHC a presentar una declaración de registro para reventa dentro de 60 días y a que sea declarada efectiva dentro de 90 días (o cinco días hábiles tras la aprobación de la SEC). Las acciones se emitirán bajo la exención de la Sección 4(a)(2).

La presentación lista el EPFA y el Acuerdo de Derechos de Registro como Anexos 10.1 y 10.2. No se divulgaron métricas de desempeño financiero.

2025년 8월 4일, La Rosa Holdings Corp.("LRHC")는 기관 투자자와 주식 매입 시설 계약(EPFA)을 체결했다고 8-K 보고서를 통해 발표했습니다.

이 시설은 LRHC에 최대 1억 5천만 달러 상당의 신주 보통주를 판매할 권리(의무는 아님)를 부여하며, 계약 체결 후 첫 거래일 기준으로 (i) 36개월이 경과하거나 (ii) 약정금액이 전부 소진되는 시점 중 빠른 시점까지 유효합니다. 가격은 현재 시장 가격을 기준으로 결정됩니다. 회사는 미리 통지된 사항이 없으면 5거래일 전에 통지하여 EPFA를 취소할 수 있습니다.

전체 약정을 이용하려면 LRHC는 계약일로부터 60일 이내에 주주 승인(회의 또는 서면 동의)을 받아야 하며, 서면 동의로 승인을 받은 경우 Schedule 14C를 제출해야 합니다. 함께 체결된 등록 권리 계약은 LRHC가 60일 이내에 재판매 등록 서류를 제출하고 90일 이내(또는 SEC 승인 후 5영업일 이내)에 효력을 발생시키도록 의무화합니다. 주식은 섹션 4(a)(2) 면제를 통해 발행됩니다.

보고서에는 EPFA와 등록 권리 계약이 각각 부속서 10.1과 10.2로 기재되어 있습니다. 재무 성과 지표는 공개되지 않았습니다.

Le 4 août 2025, La Rosa Holdings Corp. (« LRHC ») a déposé un 8-K annonçant la conclusion d’un Contrat de Facilité d’Achat d’Actions (EPFA) avec un investisseur institutionnel.

Cette facilité donne à LRHC le droit—mais pas l’obligation—de vendre jusqu’à 150 millions de dollars US d’actions ordinaires nouvellement émises sur une période se terminant à la première échéance entre (i) 36 mois après le premier jour de négociation suivant la signature, ou (ii) lorsque l’engagement est entièrement utilisé. Le prix sera basé sur le prix du marché en vigueur. La société peut annuler l’EPFA avec un préavis de cinq jours de bourse, à condition qu’aucun avis préalable ne soit en attente.

Pour accéder à l’intégralité de l’engagement, LRHC doit obtenir l’approbation des actionnaires (par assemblée ou consentement écrit) dans les 60 jours suivant la date de l’accord et déposer un Schedule 14C si l’approbation est obtenue par consentement écrit. Un Accord sur les Droits d’Enregistrement associé oblige LRHC à déposer une déclaration d’enregistrement de revente dans les 60 jours et à la faire rendre effective dans les 90 jours (ou cinq jours ouvrables après l’approbation de la SEC). Les actions seront émises sous l’exemption de la Section 4(a)(2).

Le dépôt liste l’EPFA et l’Accord sur les Droits d’Enregistrement comme Annexes 10.1 et 10.2. Aucune donnée financière n’a été divulguée.

Am 4. August 2025 hat La Rosa Holdings Corp. („LRHC“) ein 8-K eingereicht, in dem bekanntgegeben wurde, dass eine Aktienkauf-Fazilitätsvereinbarung (EPFA) mit einem institutionellen Investor abgeschlossen wurde.

Die Fazilität gibt LRHC das Recht—aber nicht die Verpflichtung—bis zu 150 Millionen US-Dollar an neu ausgegebenen Stammaktien über einen Zeitraum zu verkaufen, der endet, je nachdem, was früher eintritt: (i) 36 Monate nach dem ersten Handelstag nach der Unterzeichnung oder (ii) wenn die Verpflichtung vollständig ausgeschöpft ist. Die Preisgestaltung erfolgt basierend auf dem aktuellen Marktpreis. Das Unternehmen kann die EPFA mit einer Frist von fünf Handelstagen kündigen, sofern keine Vorausbenachrichtigungen ausstehen.

Um die volle Verpflichtung in Anspruch zu nehmen, muss LRHC innerhalb von 60 Tagen nach dem Vertragsdatum die Aktionärszustimmung (durch Versammlung oder schriftliche Zustimmung) einholen und ein Schedule 14C einreichen, falls die Zustimmung schriftlich erfolgt. Eine begleitende Registrierungsrechtsvereinbarung verpflichtet LRHC, innerhalb von 60 Tagen eine Wiederverkaufsregistrierung einzureichen und diese innerhalb von 90 Tagen (oder fünf Werktagen nach SEC-Freigabe) wirksam werden zu lassen. Die Aktien werden gemäß der Section 4(a)(2)-Ausnahme ausgegeben.

Die Einreichung listet die EPFA und die Registrierungsrechtsvereinbarung als Anlagen 10.1 und 10.2 auf. Es wurden keine finanziellen Leistungskennzahlen offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fletcher Robert S

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F 441 D $392.73 12,242 D
Common Stock 162 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Robert S Fletcher 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How much capital can La Rosa Holdings (LRHC) raise under the new Equity Purchase Facility?

Up to $150 million in newly issued common shares over a period of up to 36 months.

What approvals are required before LRHC can fully use the EPFA?

LRHC must obtain stockholder approval—by meeting or written consent—within 60 days of 4 Aug 2025.

How will the shares issued under the EPFA be priced?

Pricing will be based on the prevailing Market Price as defined in the agreement.

When must LRHC file the resale registration statement for EPFA shares?

A Resale Registration Statement is due within 60 days of the Agreement Date and must be declared effective within 90 days (subject to SEC review).

Can LRHC terminate the Equity Purchase Facility?

Yes. The Company may terminate the EPFA with five trading days’ written notice, provided no pending advances exist.
Stryker Corp

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

144.43B
361.26M
5.36%
80.97%
1.25%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE